Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Sclerosis, Scleroderma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07839221
What this trial is testing

Combined Growth Differentiation Factor-15 (GDF-15) and Lung Ultrasound for ILD Screening in Rheumatoid Arthritis and Systemic Sclerosis

Who this might be right for
Rheumatoid Arthritis (RA)Systemic Sclerosis (SSc)Interstitial Lung Disease (ILD)
Assiut University 110
Early research (Phase 1)Study completedNCT00946699
What this trial is testing

The Safety and Tolerability of MEDI-551 in Scleroderma

Who this might be right for
Scleroderma
MedImmune LLC 50
Early research (Phase 1)Looking for participantsNCT06822881
What this trial is testing

CT1190B in the Treatment of Patients With Moderate to Severe Refractory Systemic Lupus Erythematosus (SLE) or Refractory/Progressive Systemic Sclerosis (SSc)

Who this might be right for
Systemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)
Beijing GoBroad Hospital 27
Not applicableStudy completedNCT00909337
What this trial is testing

Early Therapy of Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary HypertensionSystemic Sclerosis
Medical University of Graz 10
Large-scale testing (Phase 3)Study completedNCT00626665
What this trial is testing

Randomised Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma

Who this might be right for
Raynaud Disease
Sanjay Gandhi Postgraduate Institute of Medical Sciences 25
Not applicableStudy completedNCT00318188
What this trial is testing

Effects of a Personalized Standardized Rehabilitation Program in Systemic Sclerosis

Who this might be right for
Systemic Scleroderma
Assistance Publique - Hôpitaux de Paris 220
Not applicableNot Yet RecruitingNCT07642297
What this trial is testing

TL1A Inhibition in Systemic Sclerosis-Related Skin Fibrosis and Immunological Alterations: A Proof-of-Concept In Vitro Study (FIBROSTOP)

Who this might be right for
Systemic Sclerosis (SSc)Diffuse Cutaneous Systemic SclerosisSkin Fibrosis
Fondazione Policlinico Universitario Campus Bio-Medico 20
Post-approval studies (Phase 4)Ended earlyNCT03388255
What this trial is testing

Efficacy and Safety of PLACENTEX ® i.m. in Patients With Scleroderma Diseases

Who this might be right for
Scleroderma Disease
Mastelli S.r.l 25
Testing effectiveness (Phase 2)Study completedNCT02370784
What this trial is testing

Atorvastatin for Microvascular Endothelial Function and Raynaud in Early Diffuse Scleroderma

Who this might be right for
Scleroderma
Robyn T. Domsic, MD, MPH 24
Not applicableStudy completedNCT03419208
What this trial is testing

Scleroderma Patient-centered Intervention Network (SPIN) Hand Program

Who this might be right for
SclerodermaSystemic Sclerosis
Lady Davis Institute 466
Not applicableUnknownNCT06544343
What this trial is testing

Integration of Remote Monitoring in the Management of Chronic Immunosuppressive Therapy

Who this might be right for
Rheumatoid ArthritisPsoriatic ArthritisSystemic Lupus Erythematosus+3 more
University Of Perugia 190
Testing effectiveness (Phase 2)Study completedNCT03351114
What this trial is testing

Pilot Study Evaluating the Efficacy of a Topical PDE4 Inhibitor for Morphea

Who this might be right for
Morphea
Duke University 8
Not applicableUnknownNCT01840748
What this trial is testing

Development and Prevention of Pulmonary Hypertension in Systemic Sclerosis

Who this might be right for
Systemic SclerosisPulmonary Hypertension
University of Paris 5 - Rene Descartes 960
Testing effectiveness (Phase 2)Temporarily pausedNCT04166552
What this trial is testing

Evaluation of Safety, Tolerability and Preliminary Efficacy of EHP-101 in Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Emerald Health Pharmaceuticals 36
Very early researchWithdrawnNCT04656704
What this trial is testing

Hyaluronidase in Treating Oral Microstomia in Patients With Sclerosing Skin Disease

Who this might be right for
MicrostomiaSclerodermaCREST Syndrome+2 more
Brigham and Women's Hospital
Not applicableUnknownNCT04264728
What this trial is testing

Adult-onset Generalized Morphea

Who this might be right for
Generalized Morphea
University Hospital, Strasbourg, France 100
Post-approval studies (Phase 4)Study completedNCT03630198
What this trial is testing

Pain Outcomes Following Intralesional Corticosteroid Injections

Who this might be right for
KeloidAlopecia AreataAcne+12 more
Vanderbilt University Medical Center 31
Not applicableStudy completedNCT05528809
What this trial is testing

Quantification and Characterization of Circulating Epithelial and Endothelial Cells in Gougerot-Sjögren Syndrome, Compared to Systemic Sclerosis

Who this might be right for
Primary Gougerot-Sjögren SyndromeSystemic Sclerosis, Diffuse
University Hospital, Montpellier 40
Not applicableUnknownNCT06412614
What this trial is testing

Evaluation of Patients With Systemic Sclerosis Without Specific or Associated Autoantibodies

Who this might be right for
Systemic Sclerosis
Central Hospital, Nancy, France 300
Not applicableStudy completedNCT02212249
What this trial is testing

Soluble VE-cadherin and VE-cadherin Antibody in Sclerodermic Sclerosis

Who this might be right for
Primary Raynaud DiseaseSystemic Sclerosis
University Hospital, Grenoble 85
Next Page